Stock Events

Stock Events

21st North 

$0
5
-$0-0% Wednesday 13:30

Statistics

Day High
0
Day Low
0
52W High
0.01
52W Low
0
Volume
125
Avg. Volume
-
Mkt Cap
2,128.2
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

3FebExpected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
0
0.33
0.67
1
Expected EPS
0
Actual EPS
N/A

Financials

-53.45%Profit Margin
Unprofitable
2012
2013
2014
14.24MRevenue
-7.61MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ULGX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific Corporation competes in the medical devices sector, offering products that could directly compete with 21st North's offerings in urology and pelvic health.
Medtronic
MDT
Mkt Cap102.71B
Medtronic plc is a global leader in medical technology, services, and solutions, with a broad range of products that could compete with 21st North's medical devices.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson operates in the medical devices segment through its subsidiary Ethicon, among others, offering products that could compete in similar markets as 21st North.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories offers medical devices across various segments, including cardiovascular and neuromodulation, potentially competing with 21st North's product lines.
Stryker
SYK
Mkt Cap112.88B
Stryker Corporation specializes in medical and surgical equipment, including products for minimally invasive procedures, which could compete with 21st North's technologies.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but its innovations in minimally invasive technology could see it venturing into areas competitive with 21st North.
Edwards Lifesciences
EW
Mkt Cap48.42B
Edwards Lifesciences Corporation is known for its heart valves and hemodynamic monitoring, and its push into new medical device territories could make it a competitor.
Intuitive Surgical
ISRG
Mkt Cap162.13B
Intuitive Surgical, Inc. specializes in robotic-assisted surgery, a field that could intersect with 21st North's interests in innovative surgical technologies.
Baxter International
BAX
Mkt Cap8.88B
Baxter International Inc. provides a broad array of medical devices and services that could compete with 21st North in areas like renal care and advanced surgery.
Hologic
HOLX
Mkt Cap16.97B
Hologic, Inc. focuses on women's health and cancer diagnostics, areas that could see overlap with 21st North's product offerings in healthcare solutions.

About

Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.
Show more...
CEO
Bryon Merade
Employees
61
Country
United States
ISIN
US9172731047

Listings

OTC Link
US
ULGX

0 Comments

Share your thoughts

FAQ

What is 21st North stock price today?▼
The current price of ULGX is $0 USD — it has decreased by -0% in the past 24 hours. Watch 21st North stock price performance more closely on the chart.
What is 21st North stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange 21st North stocks are traded under the ticker ULGX.
What is 21st North market cap?▼
Today 21st North has the market capitalization of 2,128.2
What is 21st North revenue for the last year?▼
21st North revenue for the last year amounts to 14.24M USD.
What is 21st North net income for the last year?▼
ULGX net income for the last year is -7.61M USD.
How many employees does 21st North have?▼
As of May 06, 2026, the company has 61 employees.
In which sector is 21st North located?▼
21st North operates in the Health & Wellness sector.
When did 21st North complete a stock split?▼
21st North has not had any recent stock splits.
Where is 21st North headquartered?▼
21st North is headquartered in Minneapolis, United States.